T40.7X2D Poisoning by cannabis (derivatives), intentional self-harm, subsequent encounter

Name of the Condition

• Common name: Intentional self-harm by cannabis (derivatives) poisoning
• Medical terms: Deliberate cannabis (derivatives) self-poisoning, subsequent encounter

Summary

This ICD code describes intentional self-harm by cannabis (derivatives) during a subsequent encounter. It applies to cases where a patient intentionally exposes themselves to cannabis products to cause harm, and the encounter represents follow-up care after the initial episode. The code is specific to the subsequent phase of management for this condition.

Causes

Intentional self-harm may result from deliberate ingestion or exposure to cannabis products with the intent to cause harm. This can include misuse of high-potency formulations, intentional overconsumption, or other deliberate actions leading to toxicity. The subsequent encounter indicates ongoing care following the initial event.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety)
• Prior episodes of self-harm or suicidal behavior
• Access to cannabis products
• Concurrent substance use disorders
• Social or environmental stressors

Symptoms

• Altered mental status or confusion
• Nausea, vomiting, or abdominal pain
• Tachycardia or palpitations
• Dizziness or impaired coordination
• Anxiety, paranoia, or psychosis
• Respiratory depression (with high doses)

Diagnosis

Diagnosis involves clinical evaluation of symptoms, patient history, and confirmation of intentional self-harm. Toxicology screening may be used to detect cannabis exposure. The subsequent encounter context is confirmed through documentation of prior episodes and ongoing care needs.

Treatment Options

Treatment focuses on managing acute symptoms, providing psychological support, and addressing underlying mental health concerns. Interventions may include monitoring, symptomatic care, and referral to mental health services. Follow-up care is tailored to the patient’s ongoing needs.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and the effectiveness of treatment. Follow-up care is critical to address mental health and prevent recurrence. Ongoing monitoring and support improve outcomes for patients with intentional self-harm.

Complications

• Respiratory failure (with severe exposure)
• Cardiovascular instability
• Persistent psychiatric symptoms
• Recurrent self-harm or suicidal behavior

Lifestyle & Prevention

• Secure storage of cannabis products
• Access to mental health resources
• Education on safe use and risks
• Support for substance use disorders

When to Seek Professional Help

Seek immediate care for severe symptoms (e.g., respiratory distress, altered consciousness) or if self-harm is suspected. Ongoing professional support is recommended for mental health concerns or recurrence of harmful behaviors.

Tips for Medical Coders

Use this code for subsequent encounters related to intentional self-harm by cannabis (derivatives). Document the intent (self-harm), substance (cannabis derivatives), and encounter type (subsequent) clearly. Ensure alignment with clinical notes and coding guidelines.